Bengaluru’s Cent Secures $15M Series A to Revolutionize Preventive Healthcare
In a significant boost for India’s health-tech ecosystem, Bengaluru-based preventive healthcare startup Cent has successfully closed a $15 million Series A funding round. The capital injection marks a pivotal moment for the company as it looks to aggressively scale its screening operations and further refine its proprietary AI-driven radiology technology.
The funding round was co-led by prominent investment firms Blume Ventures and South Park Commons, signaling strong institutional confidence in Cent’s vision to integrate advanced artificial intelligence into routine diagnostic workflows. By focusing on early detection and preventive care, Cent is positioning itself as a critical player in addressing the growing demand for efficient, tech-enabled healthcare solutions in India.
Scaling AI-Driven Diagnostics
Cent has carved a niche for itself by bridging the gap between traditional radiology and modern AI capabilities. The startup’s platform is designed to assist clinicians in identifying health risks at an earlier stage, potentially reducing the burden on the healthcare system by shifting the focus from reactive treatment to proactive screening. With this fresh infusion of capital, the company plans to expand its footprint across major Indian cities, enhancing its screening infrastructure and accelerating the development of its AI algorithms.
The participation of South Park Commons, known for backing high-potential technical founders, alongside the deep local expertise of Blume Ventures, provides Cent with a robust strategic foundation. As the Indian healthcare sector continues to undergo a digital transformation, Cent’s ability to combine clinical precision with scalable technology makes it a startup to watch closely in the coming quarters.
For the healthcare industry, this investment underscores a broader trend: the increasing reliance on data-backed, AI-assisted diagnostics to improve patient outcomes. As Cent scales its operations, the company is set to play a vital role in making high-quality preventive care more accessible and accurate for the masses.